Urogen Pharma reports wider-than-expected fourth-quarter loss

Reuters
10 Mar
March 10 (Reuters) - Urogen Pharma Ltd ::
*UROGEN PHARMA Q4 OPERATING EXPENSES USD 49.752 MILLION
*UROGEN PHARMA Q4 BASIC EPS USD -0.8
*UROGEN PHARMA Q4 OPERATING INCOME USD -27.658 MILLION VERSUS. IBES ESTIMATE USD -22.3 MILLION
*UROGEN PHARMA Q4 PRETAX PROFIT USD -34.863 MILLION VERSUS. IBES ESTIMATE USD -28.6 MILLION
*UROGEN PHARMA Q4 REVENUE USD 24.565 MILLION VERSUS. IBES ESTIMATE USD 25.6 MILLION
*UROGEN PHARMA Q4 NET INCOME USD -37.512 MILLION VERSUS. IBES ESTIMATE USD -28.5 MILLION

((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))
Source Date/Time = 10-MAR-202512:00:01.41 GMT

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10